Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study

✍ Scribed by Papatheodoridis, G. V.; Manolakopoulos, S.; Touloumi, G.; Vourli, G.; Raptopoulou-Gigi, M.; Vafiadis-Zoumbouli, I.; Vasiliadis, T.; Mimidis, K.; Gogos, C.; Ketikoglou, I.; Manesis, E. K.

• Book ID: 125902236
• Publisher: BMJ Publishing Group
• Year: 2011
• Tongue: English
• Weight: 138 KB
• Volume: 60
• Category: Article
• ISSN: 0017-5749
• DOI: 10.1136/gut.2010.221846